Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.

The collective voice of early phase COVID-19 vaccine trial participants: Insights for improving confidence in novel vaccines.

Journal article

Thomas TM. et al, (2023), Human vaccines & immunotherapeutics, 19

HBV001: Phase I study evaluating the safety and immunogenicity of the therapeutic vaccine ChAdOx1-HBV.

Journal article

Cargill T. et al, (2023), JHEP reports : innovation in hepatology, 5

Long COVID research: an update from the PHOSP-COVID Scientific Summit.

Journal article

Brightling CE. et al, (2023), The Lancet. Respiratory medicine, 11, e93 - e94

Persistence of SARS-CoV-2 antibodies over 18 months following infection: UK Biobank COVID-19 Serology Study.

Journal article

Bešević J. et al, (2023), Journal of epidemiology and community health

Burkholderia pseudomallei and melioidosis.

Journal article

Meumann EM. et al, (2023), Nat Rev Microbiol

Cellular iron governs the host response to malaria.

Journal article

Wideman SK. et al, (2023), PLoS pathogens, 19

Load More